Clinical Trial Update: Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating rolapitant hydrochloride to prevent nausea and vomiting in patients with locally advanced sarcoma undergoing chemotherapy; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• rolapitant hydrochloride (rolapitant hydrochloride)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally Advanced Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2021-08-09